Fundraising FoxOxford Angel Fund
Venture capitalSan Francisco · Pre-Seed–Seed · 1 people tracked
Find your way into Oxford Angel Fund
Each arrow is one introduction. Sign up to fill in the first one.
Ask Kevin Simmons to introduce you to Neil Wolff
You →Kevin · together at Oxford Angel Fund →Neil
Sign up to find every way you can get introduced to Oxford Angel Fund
- Your email: who you already know at Oxford Angel Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Oxford Angel Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Oxonian Ventures focuses on backing early-stage companies founded by Oxford University alumni. The fund gives Oxford-affiliated accredited investors exclusive access to invest in this pipeline of Oxonian-founded ventures, aiming to support the growth of Oxford innovation while producing attractive returns. It positions itself as the leading early-stage venture fund tied to the Oxford alumni network, having raised multiple funds and built a portfolio of Oxonian-founded companies since its founding.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 10 of 10 portfolio companiesHealthtech ×8Biotech ×7AI & Machine Learning ×6Deep Tech ×3Digital Health ×3Medical Devices ×3SaaS ×2Advanced Manufacturing ×1
HQs:United States×10
Investments · 10 tracked
founders shown can be your intro pathBy year:2024 · 12022 · 12 dated
AOA Dx develops a blood-based liquid biopsy platform using mass spectrometry and machine learning to detect ovarian cancer at early stages through tumor-associated biomarkers in serum.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesDenver, US
Oriana Papin-Zoghbi(Founder)inAlex Fisher(Founder/COO)inAnna Jeter(Founder)inOriana Zoghbi-Harb(Executive Officer, Director)Abigail Mcelhinny(Executive Officer)in
BoardSurbhi Sarna(Director)in
Co-investorsAlleyCorpGood Growth CapitalJoyance PartnersY CombinatorAstiaAurum Venture Partners+33 more
Apero is a healthcare software platform that provides scheduling, visit notes, revenue cycle management, patient billing, prescriptions, and financial reporting for medical practices.
HealthtechSaaSSan Francisco, US
Jacinda Shelly(Founder)inNick Shelly(Founder)in
Co-investorsInitialized CapitalJude GomilaOxonian VenturesSoma CapitalUpHonest CapitalVentureSouq+10 more
BluumBio identifies and deploys naturally occurring enzymes from fungi, trees, and bacteria to remove industrial pollutants from soil, air, and water.
BiotechCleantechHealthtechImpact & Social GoodSan Francisco, US
Katherine French(Founder)in
Co-investorsCollaborative FundHAWKTAILOlive Tree CapitalOxonian VenturesY CombinatorAgrolimen Ventures+8 more
Conductor develops AI algorithms and control software for quantum computing, helping researchers and engineers optimize qubit architectures and scaling in semiconductor-based quantum systems.
Advanced ManufacturingAI & Machine LearningDeep TechQuantum ComputingSan Francisco, US
Brandon Severin(Co-Founder & CEO)inJoel Pendleton(Co-Founder & CTO)in
Co-investorsDG Daiwa VenturesMoonfire VenturesMyAsiaVCOlive Tree CapitalOUTBOUND CAPITALOxonian Ventures+16 more
ExcepGen develops biologics, gene therapies, and vaccines using synthetic biology approaches to create therapies that operate outside normal cellular regulation constraints.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Thomas Folliard(Founder)in
Co-investorsGravityJude GomilaOxonian VenturesPi CampusY CombinatorZAKA VC+8 more
Granza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
BiotechDeep TechDigital HealthHealthtechSan Francisco, US
Prof. Dustin(Co-founder)Ashwin Nandakumar(Founder)inAshwin Jainarayanan(Founder)inAshwin Menon Nandakumar(Founder)in
Co-investorsFelicis VenturesMetaplanetOxonian VenturesPioneerRitual CapitalY Combinator+4 more
Ligo develops computational tools for enzyme design by combining large language models with specialized neural networks to enable scientists and AI agents to discover new enzymes and biological functions.
AI & Machine LearningBiotechClimate TechDeep TechHealthtechSan Francisco, US
Edward Harris(Founder)inEmily Egerton-Warburton(Founder)inArda Goreci(Founder)in
Co-investorsA.Capital VenturesHAWKTAILOxonian VenturesSoma CapitalTranspose Platform ManagementWayfinder Ventures+15 more
Probably Genetic operates a platform for diagnosing genetic diseases, providing comprehensive genetic data and testing to patients and healthcare providers.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Lukas Lange(Founder)in
Co-investorsAsymmetric Capital PartnersCalm/Storm VCManta Ray VenturesOxonian VenturesRecode VenturesThink+ Ventures Management, Llc+6 more
Proof provides online notarization and identity verification tools to establish trust for agreements and records executed remotely.
CybersecurityEnterprise SoftwareFintechGovTechLegalTechMarketplacesSaaS
Pat Kinsel(Founder & CEO)inLeandra Fishman(Chief Revenue Officer)Eric Fleischman(Chief Technology Officer)Renee Hunter(Chief Legal Officer)Darren Louie(Head of Product)Ian Macallister
Co-investorsCamber CreekCanapi VenturesCapitalGCurql Collective, LLCEthos VCJovono+7 more
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Co-Founder & CEO)inIrsyad Khairil(Co-Founder & CTO)in
Co-investorsHoxton VenturesLongeVCMetaplanetOxonian VenturesP53 InvestSynBioVen+8 more
Portfolio news
latest coverage across their companiesProbably Genetic · trysignalbase.com · Mar 24, 2026
Conductor Quantum · ycombinator.com · Jan 21, 2026
Valink Therapeutics · finsmes.com · Oct 20, 2025
Frequently asked questions
- How many investments has Oxford Angel Fund made?
- Oxford Angel Fund has 10 tracked investments.
- What stage does Oxford Angel Fund invest at?
- Oxford Angel Fund invests at the Pre-Seed, Seed stages.
- What sectors does Oxford Angel Fund focus on?
- Oxford Angel Fund focuses on Crypto & Web3, Sector Agnostic.
- Where is Oxford Angel Fund located?
- Oxford Angel Fund is headquartered in San Francisco, US.
Images
Similar investors
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
August Capital is a venture capital firm that invests in a small number of companies, providing hands-on support to entrepreneurs building their businesses.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Blueyard is a small equal partnership with offices in the US and Europe, investing in early-stage companies.
Cherubic Ventures is known for investing before a startup even launches or reaches product-market fit, often as the first institutional investor, while also setting aside half of its latest fund for follow-on support all the way through pre-IPO; it was also one of the first venture firms to operate as a solo general partner and has grown into one of the largest funds run that way. Founded by Matt Cheng, who previously built two companies that each reached over $1 billion in public market value, the firm was designed from the start to invest across both the U.S. and Asia, backing early breakout companies in places like Croatia, Bangladesh, Japan, and Taiwan in addition to the U.S., with its Taipei roots still central to its identity alongside its Silicon Valley presence.